Aarti Pharmalabs Limited (AARTIPHARM.NS) NSE

761.35

-19.8(-2.53%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap68.33B
Enterprise Value72.38B
P/E Ratio28.78
PEG Ratio-2.87
Price/Sales Ratio3.62
Price/Book Ratio3.37
Enterprise/Revenue3.94
Enterprise/EBITDA16.75

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.18

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue21.15B
Revenue/Share210.29
Gross Profit9.87B
EBITDA4.74B
Net Income2.72B
Diluted EPS30.04

Balance Sheet

Total Cash555.56M
Total Cash/Share6.13
Total Debt6.59B
Total Debt/Equity0.32
Current Ratio1.64
Book Value Per Share225.75

Price History

52-Week Change20.4
52-Week High971
52-Week Low568.1
Moving Average 50 Days766.5
Moving Average 200 Days818.77

Statistics

Average Volume202,317
Shares Outstanding90.65M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.66
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A